Table 2. Baseline characteristics of the patients in different risk groups.
| Characteristics | TCGA-LIHC cohort | ICGC-LIRP-JI cohort | ||||
| High risk | Low risk | P value | High risk | Low risk | P value | |
| Age | ||||||
| < 60 year | 74 (20.3%) | 91 (24.9%) | 0.082 | 28 (12.1%) | 16 (6.9%) | 0.540 |
| ≥ 60 year | 108 (29.6%) | 92 (25.2%) | 128 (55.4%) | 59 (25.5%) | ||
| Gender | ||||||
| Female | 61 (16.7%) | 58 (15.9%) | 0.710 | 40 (17.3%) | 21 (9.1%) | 0.703 |
| Male | 121 (33.2%) | 125 (34.2%) | 116 (50.2%) | 54 (23.4%) | ||
| Grade | ||||||
| G1+G2 | 104 (28.5%) | 126 (34.5%) | 0.016 | – | – | |
| G3+G4 | 76 (20.8%) | 54 (14.8%) | – | – | ||
| unknown | 2 (0.5%) | 3 (0.8%) | – | – | ||
| Stage | ||||||
| I + II | 116 (31.8%) | 138 (37.8%) | 0.023 | 86 (37.2%) | 55 (23.8%) | 0.008 |
| III + IV | 52 (14.2%) | 35 (9.6%) | 70 (30.3%) | 20 (8.7%) | ||
| unknown | 14 (3.8%) | 10 (2.7%) | 0 (0%) | 0 (0%) | ||